BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22145798)

  • 1. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.
    Wilson LS; Pregenzer M; Basu R; Bertenthal D; Torres J; Asgari M; Chren MM
    Dermatol Surg; 2012 Apr; 38(4):570-84. PubMed ID: 22145798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
    Rogers HW; Coldiron BM
    J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
    Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
    Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
    Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
    Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?
    Linos E; Chren MM; Stijacic Cenzer I; Covinsky KE
    J Am Geriatr Soc; 2016 Aug; 64(8):1610-5. PubMed ID: 27303932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic.
    Chren MM; Sahay AP; Sands LP; Maddock L; Lindquist K; Bertenthal D; Bacchetti P
    Med Care; 2004 Oct; 42(10):1019-26. PubMed ID: 15377935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
    Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
    Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
    Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
    JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
    Lear W; Mittmann N; Barnes E; Breen D; Murray C
    J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.
    Chren MM; Torres JS; Stuart SE; Bertenthal D; Labrador RJ; Boscardin WJ
    Arch Dermatol; 2011 May; 147(5):540-6. PubMed ID: 21576572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
    Zabielinski M; Leithauser L; Godsey T; Gloster HM
    Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs micrographic surgery referral patterns: the University of Missouri experience.
    Gaston DA; Naugle C; Clark DP
    Dermatol Surg; 1999 Nov; 25(11):862-6; discussion 866-7. PubMed ID: 10594598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
    Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
    Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
    Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
    J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
    Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
    J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost of nonmelanoma skin cancer treatment in the United States.
    Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
    Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
    Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
    Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
    Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.